BioPharma Credit PLC Confirmation of Delisting from TISE (4194O)
October 08 2021 - 1:00AM
UK Regulatory
TIDMBPCR
RNS Number : 4194O
BioPharma Credit PLC
08 October 2021
LEI: 213800AV55PYXAS7SY24
8 October 2021
BIOPHARMA CREDIT PLC
(THE "COMPANY")
CONFIRMATION OF DELISTING FROM THE INTERNATIONAL EXCHANGE
AUTHORITY
Further to its announcement on 30 September 2021, BioPharma
Credit plc (the "Company" or "BioPharma Credit") confirms the
cancellation of the admission of its ordinary shares ("Ordinary
Shares") to listing and trading on the Official List of The
International Exchange Authority (the "TISE Delisting"). The TISE
Delisting was approved by shareholder vote at the general meeting
held on 30 September 2021.
The TISE Delisting is expected to become effective today.
The Ordinary Shares will continue to be admitted to listing on
the Official List of the Financial Conduct Authority and to trading
on the Premium Segment of the London Stock Exchange plc's Main
Market.
For Further Information
BioPharma Credit plc
Via Link Company Matters Limited
Company Secretary
+44 (0)1392 477 509
J.P. Morgan Cazenove
William Simmonds / Harry Randall (Corporate Finance)
+44 (0)20 7742 4000
Buchanan
David Rydell / Mark Court / Jamie Hooper / Henry Wilson
+44 (0)20 7466 5000
Biopharmacredit@buchanan.uk.com
About BioPharma Credit plc:
BioPharma Credit PLC is London's only listed specialist investor
in debt from the life sciences industry and joined the LSE on 27
March 2017. The Company seeks to provide long-term shareholder
returns, principally in the form of sustainable income
distributions from exposure to the life sciences industry. The
Company seeks to achieve this objective primarily through
investments in debt assets secured by royalties or other cash flows
derived from the sales of approved life sciences products.
Visit the BioPharma Credit website at http://bpcruk.com for more
information.
Capitalised terms used but not defined in this announcement will
have the same meaning as set out in the circular published by the
Company on 10 September 2021 unless the context otherwise
requires.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCQDLFBFBLFFBL
(END) Dow Jones Newswires
October 08, 2021 02:00 ET (06:00 GMT)
Biopharma Credit (LSE:BPCR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Biopharma Credit (LSE:BPCR)
Historical Stock Chart
From Apr 2023 to Apr 2024